Freedom from coeliac disease
The Common Good

Freedom from coeliac disease

Most of us don’t think twice about eating a piece of toast in the morning, however for 1 in 70 Australians with coeliac disease this is simply not an option. But that may change and give those the freedom to enjoy a better quality of life. Not long ago you supported breakthrough research to fight coeliac disease utilising hookworms – that’s right, a parasite may be the key to helping coeliac patients live a normal life.

Researchers Dr John Croese and Dr Paul Giacomin are hoping to develop a drug with the help of these worms, who they believe secrete an anti-inflammatory protein.

We were excited to announce that with the help of our donors, researchers Dr John Croese and Dr Paul Giacomin secured more than $300,000 worth of funding from the Queensland Government to study and trial this treatment and research its potential benefits for coeliac sufferers.

Initial treatment trials have shown promising results, with previously gluten-intolerant patients being able to eat a small bowl of pasta without any adverse effects. The researchers are studying how to mimic the gluten-tolerating effects of the unusual treatment in order to create a pill-based medication.

If successful, this fascinating research will change the lives of millions of coeliac patients worldwide. We’ll keep you updated with the progress.

Support The Common Good here.

Published: June 27, 2019

Related news & events

The journey from the Cycle of Giving to the Tour de Brisbane

The Common Good

The journey from the Cycle of Giving to the Tour de Brisbane

In 2006, Mary and Mal Long started an event called Cycle of Giving to show their gratitude to Mal’s donor family and medical team.

Find out more

Chain Reaction Challenge 2024: Helping Kids visiting The Prince Charles Hospital

The Common Good

Chain Reaction Challenge 2024: Helping Kids visiting The Prince Charles Hospital

In March, dozens of cyclists from Brisbane will take part in a 1000 km cycle in and around Adelaide for the Chain Reaction Challenge 2024.

Find out more

30-year-old heart transplant recipient’s journey to the 2024 Tour de Brisbane

Heart Disease

30-year-old heart transplant recipient’s journey to the 2024 Tour de Brisbane

A Perth father who received a heart transplant three years ago is preparing to take part in the 2024 Tour de Brisbane. Read more about his journey and support his ride here.

Find out more

International Day of Women and Girls in Science 2024

The Common Good

International Day of Women and Girls in Science 2024

This February, we acknowledge International Day of Women and Girls in Science 2024 and some of the remarkable women who are making a difference in STEM.

Find out more

Marfan and Aortopathy Conference Brisbane 2024

The Common Good

Marfan and Aortopathy Conference Brisbane 2024

The Marfan and Aortopathy Conference Brisbane 2024 is on Saturday, April 20, at The Prince Charles Hospital. Click here for more details.

Find out more

What is Marfan Syndrome?

The Common Good

What is Marfan Syndrome?

What is Marfan Syndrome? It affects about 1 in 5000 people across the globe, and for some, it can lead to serious or even life-threatening complications. Learn more here.

Find out more

The Café for The Common Good finds new home at Caboolture Hospital

Social Enterprise

The Café for The Common Good finds new home at Caboolture Hospital

Caboolture Hospital Café: In exciting news, our café has a new home in the hospital’s recently opened Clinical Services Building.

Find out more

Take a walk down Memory Lane at The Prince Charles Hospital

Ageing

Take a walk down Memory Lane at The Prince Charles Hospital

At The Prince Charles Hospital, patients and their families are encouraged to take a trip down the newly completed ‘Memory Lane’. Read about the impactful project here.

Find out more

2023 Year in Review

The Common Good

2023 Year in Review

The Common Good’s 2023 Year in Review: It’s been an impactful year thanks to our phenomenal supporters! Click here to read all about it.

Find out more